Skip to content

AbbVie Inc.

ABBV· NYSECore metricsCIK 1551152

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -0.13%
Market cap
$520.54B
1.77B shares
Filings
1,041
$17.40B
Q3 2026+8.6% FY25 yoy
$4.22B
Q3 2026−1.2% FY25 yoy
$6.27B
Q3 2026+65.0% FY25 yoy
$13.98B
Q3 2026derived−0.1% FY25 yoy
$2.37
Q3 2026−1.3% FY25 yoy
$10.77B
Q3 2026−5.3% FY25 yoy
$520.54B
50.3×
7.9×
—
3.63%
2.33%

Twelve months to Sep 30, 2026 · derived

Price

$294.49+30.78%+$69.32past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$61.16BFY 2025
$61.16B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$61,160,000,000reported
FY 20242024-12-31$56,334,000,000reported
FY 20232023-12-31$54,318,000,000reported
FY 20222022-12-31$58,054,000,000reported
FY 20212021-12-31$56,197,000,000reported
FY 20202020-12-31$45,804,000,000reported
FY 20192019-12-31$33,266,000,000reported
FY 20182018-12-31$32,753,000,000reported
FY 20172017-12-31$28,216,000,000reported
FY 20162016-12-31$25,638,000,000reported
FY 20152015-12-31$22,859,000,000reported
FY 20142014-12-31$19,960,000,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$11.66B$980.00M$12.64B$6.651.77B sh+0.2%70.9%
FY2024$11.03B$1.71B$12.73B$6.291.77B sh−0.1%71.4%
FY2023$10.54B$1.97B$12.51B$5.991.77B sh−0.2%56.7%
FY2022$10.04B$1.49B$11.53B$5.711.77B sh+0.0%47.6%
FY2021$9.26B$934.00M$10.20B$5.311.77B sh+0.2%46.4%

Segments

Geography
Revenue by Geography, FY2018 to FY2025FY2018United States · FY2018 · $21.52BGermany · FY2018 · $1.29BJapan · FY2018 · $1.59BCanada · FY2018 · $730.00MChina · FY2018 · $152.00MFrance · FY2018 · $783.00MUnited Kingdom · FY2018 · $855.00MOther · FY2018 · $1.96BFY2019United States · FY2019 · $23.91BGermany · FY2019 · $909.00MJapan · FY2019 · $1.21BCanada · FY2019 · $813.00MChina · FY2019 · $195.00MFrance · FY2019 · $695.00MUnited Kingdom · FY2019 · $372.00MOther · FY2019 · $1.60BFY2020United States · FY2020 · $34.88BGermany · FY2020 · $1.05BJapan · FY2020 · $1.20BCanada · FY2020 · $1.16BChina · FY2020 · $471.00MFrance · FY2020 · $797.00MUnited Kingdom · FY2020 · $509.00MOther · FY2020 · $1.77BFY2021United States · FY2021 · $43.51BGermany · FY2021 · $1.22BJapan · FY2021 · $1.09BCanada · FY2021 · $1.40BChina · FY2021 · $857.00MFrance · FY2021 · $936.00MUnited Kingdom · FY2021 · $497.00MOther · FY2021 · $1.93BFY2022United States · FY2022 · $45.71BGermany · FY2022 · $1.34BJapan · FY2022 · $956.00MCanada · FY2022 · $1.16BChina · FY2022 · $912.00MFrance · FY2022 · $787.00MUnited Kingdom · FY2022 · $462.00MOther · FY2022 · $1.89BFY2023United States · FY2023 · $41.88BGermany · FY2023 · $1.27BJapan · FY2023 · $1.01BCanada · FY2023 · $1.08BChina · FY2023 · $950.00MFrance · FY2023 · $780.00MUnited Kingdom · FY2023 · $417.00MOther · FY2023 · $1.90BFY2024United States · FY2024 · $43.03BGermany · FY2024 · $1.47BJapan · FY2024 · $1.12BCanada · FY2024 · $1.09BChina · FY2024 · $917.00MFrance · FY2024 · $776.00MUnited Kingdom · FY2024 · $522.00MOther · FY2024 · $1.97BFY2025United States · FY2025 · $46.60BGermany · FY2025 · $1.74BJapan · FY2025 · $1.27BCanada · FY2025 · $1.22BChina · FY2025 · $1.01BFrance · FY2025 · $806.00MUnited Kingdom · FY2025 · $626.00MOther · FY2025 · $2.13B
LineFY2025ShareChange
United States$46.60B76%+8.3%
Germany$1.74B2.8%+18.6%
Japan$1.27B2.1%+13.5%
Canada$1.22B2.0%+12.3%
China$1.01B1.6%+9.7%
France$806.00M1.3%+3.9%
United Kingdom$626.00M1.0%+19.9%
Other$2.13B3.5%+8.1%
Total$61.16B

From the 10-K filed Feb 20, 2026ABBV

Pharmaceutical preparations

AbbVie Inc. is the 5th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

AbbVie Inc. · CIK 1551152 · Engraved from SEC EDGAR